A recent wave of diversification strategy by pharmaceutical groups showcased apparent and heightened interest in China's animal health industry. Boehringer Ingelheim announced its €12 million ($15.9 million) investment in mid-March to build its Asian Veterinary...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)